747 results on '"Laruelle, Marc"'
Search Results
2. Single Photon Emission Computerized Tomography Imaging of Amphetamine-Induced Dopamine Release in Drug-Free Schizophrenic Subjects
3. In Vivo Imaging of Dopamine Receptors
4. Schizophrenia: from dopaminergic to glutamatergic interventions
5. Ligand Tracer Kinetics: Theory and Application
6. Mathematical modelling of [11C]-(+)-PHNO human competition studies
7. Dopaminergic Hyperactivity in Striatum in Schizophrenia: A Failure of Cortical Glutamatergic Control?
8. Extended characterisation of the serotonin 2A (5-HT2A) receptor-selective PET radiotracer 11C-MDL100907 in humans: Quantitative analysis, test–retest reproducibility, and vulnerability to endogenous 5-HT tone
9. An evaluation of the brain distribution of [11C]GSK1034702, a muscarinic-1 (M1) positive allosteric modulator in the living human brain using positron emission tomography
10. The 5-HT2A receptor and serotonin transporter in Asperger's Disorder: A PET study with [11C]MDL 100907 and [11C]DASB
11. Within-subject comparison of striatal D2 receptor occupancy measurements using [123I]IBZM SPECT and [11C]Raclopride PET
12. Biodistribution and Radiation Dosimetry of the Serotonin 5-HT6 Ligand [11C]GSK215083 Determined from Human Whole-Body PET
13. Biodistribution and Radiation Dosimetry of the Glycine Transporter-1 Ligand 11C-GSK931145 Determined from Primate and Human Whole-Body PET
14. Increased synaptic dopamine function in associative regions of the striatum in schizophrenia
15. JOP517953_Supplementary_material – Supplemental material for Characterising the plasma-target occupancy relationship of the neurokinin antagonist GSK1144814 with PET
16. Serotonin 1A receptor availability in patients with schizophrenia and schizo-affective disorder: a positron emission tomography imaging study with [11C]WAY 100635
17. Chapter 27 Antipsychotic-Induced Changes in Striatal D2 Receptors in Schizophrenia: In Vivo Evidence from Dopamine Depletion Studies
18. Striatal dopamine transporter availability with [123I]β-CIT SPECT is unrelated to gender or menstrual cycle
19. In vivo affinity of [18F]fallypride for striatal and extrastriatal dopamine D2 receptors in nonhuman primates
20. Psychiatry — Relevance with Respect to Drug Development, Examples
21. Measuring Dopamine Synaptic Transmission with Molecular Imaging and Pharmacological Challenges: The State of the Art
22. Occupancy of brain serotonin transporters during treatment with paroxetine in patients with social phobia: a positron emission tomography study with [11C]McN 5652
23. Neuroreceptor imaging in psychiatric disorders
24. Chapter 24 Antipsychotic-Induced Changes in Striatal D2 Receptors in Schizophrenia: In Vivo Evidence from Dopamine Depletion Studies
25. 10.1 Dopamine Dysfunction in Schizophrenia
26. In Vivo Imaging of Dopamine Receptors
27. Combining PET Biodistribution and Equilibrium Dialysis Assays to Assess the Free Brain Concentration and BBB Transport of CNS Drugs
28. Within-Subject Comparison of [11C]-( + )-PHNO and [11C]raclopride Sensitivity to Acute Amphetamine Challenge in Healthy Humans
29. Coupling efficiency of brain β-adrenergic receptors to Gs protein in suicide, alcoholism and control subjects
30. Dopamine and persecutory delusions
31. Prediction of Repeat-Dose Occupancy from Single-Dose Data: Characterisation of the Relationship between Plasma Pharmacokinetics and Brain Target Occupancy
32. Imaging dopamine receptors in humans with [11C]-(+)-PHNO: Dissection of D3 signal and anatomy
33. Neurobiology of Dopamine in Schizophrenia
34. Amphetamine-induced striatal dopamine release in major depressive disorder
35. Further validation of [11C]FLB 457 as a tool to measure prefrontal cortical DA release
36. Within-subject comparison of the sensitivity of [11C]-(+)-PHNO and [11C]raclopride to amphetamine induced changes in endogenous dopamine in healthy human volunteers
37. Effect of antipsychotic treatment on cortical D1 receptors
38. Evaluation of the in vivo ED50 for the PET Radioligand, [11C]GSK-215083, in Papio anubis
39. A combined diffusion tensor imaging (DTI) and [11C]-(+)-PHNO positron emission tomography (PET) study to quantify dopamine D3/D2 receptors in pallidum
40. PET imaging of dopamine D3 receptors in humans with [11C]-(+)-PHNO: dissection of PHNO signal using two highly selective D3 antagonists
41. Awake nonhuman primate brain PET imaging without head restraint
42. Imaging Cortical Dopamine D1 Receptors Using [11C]NNC112 and Ketanserin Blockade of the 5-HT2A Receptors
43. Measuring Drug Occupancy in the Absence of a Reference Region: The Lassen Plot Re-Visited
44. DOPAMINE TRANSPORTERS, D2 RECEPTORS, AND DOPAMINE RELEASE IN GENERALIZED SOCIAL ANXIETY DISORDER
45. Neuroreceptor Imaging in Psychiatry: Theory and Applications
46. Mechanisms of action of second generation antipsychotic drugs in schizophrenia: insights from brain imaging studies
47. Mechanism of action of antipsychotic drugs: From dopamine D 2 receptor antagonism to glutamate NMDA facilitation
48. Impact of dopamine D2 receptor internalization on binding parameters of D2 PET radiotracers: Oral Presentation No.: O23
49. STRIATAL DOPAMINE D2 RECEPTOR AVAILABILITY IN OCD WITH AND WITHOUT COMORBID SOCIAL ANXIETY DISORDER: PRELIMINARY FINDINGS
50. [11C]NNC 112 Selectivity for Dopamine D1 and Serotonin 5-HT2A Receptors: A PET Study in Healthy Human Subjects
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.